170 related articles for article (PubMed ID: 18297409)
1. An evaluation of the effects of gatifloxacin on glucose homeostasis.
Onyenwenyi AJ; Winterstein AG; Hatton RC
Pharm World Sci; 2008 Oct; 30(5):544-9. PubMed ID: 18297409
[TBL] [Abstract][Full Text] [Related]
2. A retrospective, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin, or ceftriaxone.
Mohr JF; McKinnon PS; Peymann PJ; Kenton I; Septimus E; Okhuysen PC
Pharmacotherapy; 2005 Oct; 25(10):1303-9. PubMed ID: 16185173
[TBL] [Abstract][Full Text] [Related]
3. Severe dysglycemia with the fluoroquinolones: a class effect?
Aspinall SL; Good CB; Jiang R; McCarren M; Dong D; Cunningham FE
Clin Infect Dis; 2009 Aug; 49(3):402-8. PubMed ID: 19545207
[TBL] [Abstract][Full Text] [Related]
4. Outpatient gatifloxacin therapy and dysglycemia in older adults.
Park-Wyllie LY; Juurlink DN; Kopp A; Shah BR; Stukel TA; Stumpo C; Dresser L; Low DE; Mamdani MM
N Engl J Med; 2006 Mar; 354(13):1352-61. PubMed ID: 16510739
[TBL] [Abstract][Full Text] [Related]
5. Effects of gatifloxacin and levofloxacin on rates of hypoglycemia and hyperglycemia among elderly hospitalized patients.
Lodise T; Graves J; Miller C; Mohr JF; Lomaestro B; Smith RP
Pharmacotherapy; 2007 Nov; 27(11):1498-505. PubMed ID: 17963459
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of and risk factors for dysglycemia in patients receiving gatifloxacin and levofloxacin in an outpatient setting.
LaPlante KL; Mersfelder TL; Ward KE; Quilliam BJ
Pharmacotherapy; 2008 Jan; 28(1):82-9. PubMed ID: 18154478
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for hyperglycemia in hospitalized adults receiving gatifloxacin: a retrospective, nested case-controlled analysis.
Mohr JF; Peymann PJ; Troxell E; Lodise TP; Ostrosky-Zeichner L
Clin Ther; 2008 Jan; 30(1):152-7. PubMed ID: 18343251
[TBL] [Abstract][Full Text] [Related]
8. Randomized, open-label, parallel-group, multicenter study of the efficacy and tolerability of IV gatifloxacin with the option for oral stepdown gatifloxacin versus IV ceftriaxone (with or without erythromycin or clarithromycin) with the option for oral stepdown clarithromycin for treatment of patients with mild to moderate community-acquired pneumonia requiring hospitalization.
Corrêa JC; Badaró R; Bumroongkit C; Mera JR; Dolmann AL; Juárez Martínez LG; Mayrinck LR; Tamez R; Yang JY
Clin Ther; 2003 May; 25(5):1453-68. PubMed ID: 12867221
[TBL] [Abstract][Full Text] [Related]
9. Hypoglycemia associated with the use of gatifloxacin.
Bhasin R; Arce FC; Pasmantier R
Am J Med Sci; 2005 Nov; 330(5):250-3. PubMed ID: 16284487
[TBL] [Abstract][Full Text] [Related]
10. Gatifloxacin induced abnormalities in glucose homeostasis in a patient on glimepiride.
Kesavadev J; Rasheed SA
J Assoc Physicians India; 2006 Dec; 54():951-2. PubMed ID: 17334014
[TBL] [Abstract][Full Text] [Related]
11. Hypoglycemia in inpatients after gatifloxacin or levofloxacin therapy: nested case-control study.
Graumlich JF; Habis S; Avelino RR; Salverson SM; Gaddamanugu M; Jamma K; Aldag JC
Pharmacotherapy; 2005 Oct; 25(10):1296-302. PubMed ID: 16185172
[TBL] [Abstract][Full Text] [Related]
12. Risk of severe dysglycemia among diabetic patients receiving levofloxacin, ciprofloxacin, or moxifloxacin in Taiwan.
Chou HW; Wang JL; Chang CH; Lee JJ; Shau WY; Lai MS
Clin Infect Dis; 2013 Oct; 57(7):971-80. PubMed ID: 23948133
[TBL] [Abstract][Full Text] [Related]
13. Gatifloxacin produces both hypoglycemia and hyperglycemia: a retrospective study.
Haerian H; McHugh P; Brown R; Somes G; Solomon SS
Am J Med Sci; 2008 Feb; 335(2):95-8. PubMed ID: 18277115
[TBL] [Abstract][Full Text] [Related]
14. Comparing gatifloxacin and clarithromycin in pneumonia symptom resolution and process of care.
Dean NC; Sperry P; Wikler M; Suchyta MS; Hadlock C
Antimicrob Agents Chemother; 2006 Apr; 50(4):1164-9. PubMed ID: 16569825
[TBL] [Abstract][Full Text] [Related]
15. Gatifloxacin in the treatment of community-acquired pneumonias: a comparative trial of ceftriaxone, with or without macrolides, in hospitalized adult patients with mild to moderately severe pneumonia.
Mendonça JS; Yamaguti A; Corrêa JC; Badaró R
Braz J Infect Dis; 2004 Feb; 8(1):90-100. PubMed ID: 15286880
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of gatifloxacin vs ceftriaxone with a macrolide for the treatment of community-acquired pneumonia.
Dresser LD; Niederman MS; Paladino JA
Chest; 2001 May; 119(5):1439-48. PubMed ID: 11348951
[TBL] [Abstract][Full Text] [Related]
17. Severe hyperglycemia during renally adjusted gatifloxacin therapy.
Blommel AL; Lutes RA
Ann Pharmacother; 2005; 39(7-8):1349-52. PubMed ID: 15941822
[TBL] [Abstract][Full Text] [Related]
18. Gatifloxacin-associated hypoglycemia.
Ali T; Greenfield RA; Scofield H; Bronze MS
J Okla State Med Assoc; 2007 Nov; 100(11):425-8. PubMed ID: 18183859
[TBL] [Abstract][Full Text] [Related]
19. Gatifloxacin-induced dysglycemia.
Zvonar R
Am J Health Syst Pharm; 2006 Nov; 63(21):2087-92. PubMed ID: 17057046
[TBL] [Abstract][Full Text] [Related]
20. Gatifloxacin-induced hyperglycemia: a case report and summary of the current literature.
Yip C; Lee AJ
Clin Ther; 2006 Nov; 28(11):1857-66. PubMed ID: 17213006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
